← Devices & Neurotechnology
Details checkedClinical trial listing onlyHistorical/discontinuedCheckedregistry
Dominant deafness genetic epidemiology blood-sample study
Also known as: Blood sample, Peripheral whole blood sample
Institution-led study
Sponsor / Institution
Institution-led study
Program Type
Diagnostic
Modality
Genetic/Biomarker Study
Stage
Not applicable
Status
Completed
Target Gene
—
Route / Mode
Blood sample collection
Confidence
87%
Status Confidence
Status needs checking
Evidence Strength
Needs more support
Last Reviewed
2026-06-10
Geography
France
Population
genetic, familial, post-lingual
Trial IDs
1
Mechanism
Peripheral blood collection for cross-sectional genetic epidemiology of familial autosomal-dominant non-syndromic hearing loss.
Indications
Notes
Registry-verified genetic epidemiology study. It is not a biologic therapeutic program; the blood sample is a diagnostic/biobanking intervention within an academic study.
Evidence & Sources
1 structured sourcesclinicaltrials
Supports: canonicalName, company, allCompanies, isIndustrySponsored, programType, modality, mechanism, indications...
IDs: NCT01150305
Key Events
Clinical Trials (1)
Data Checks
institution-led-studyregistry-only-evidencediagnostic-study-not-productwas-therapeutic-misclassification
Related Programs
Apple AirPods Pro Hearing Health Features
Company: Apple · Hearing Aid/Software · Marketed
Nuance Audio Hearing Aid Software
Company: EssilorLuxottica · Hearing Aid/Software · Marketed
Cochlear Nucleus Nexa System
Company: Cochlear · Cochlear/Auditory Implant · Marketed
Envoy Medical Acclaim Cochlear Implant
Company: Envoy Medical · Cochlear/Auditory Implant · Phase 2/3
MED-EL SYNCHRONY Cochlear Implant System
Company: MED-EL · Cochlear/Auditory Implant · Marketed
Phonak Audéo Sphere Infinio
Company: Phonak · Hearing Aid/Software · Marketed